Mar 02, 2023 / 12:00PM GMT
Markku Jalkanen - Faron Pharmaceuticals Oy - CEO & Founder
Good afternoon. Welcome to join our presentation on year 2022. I'm here with our CFO, Toni Hänninen.
Toni Hänninen - Faron Pharmaceuticals Oy - CFO
Good afternoon from my side as well and welcome.
Markku Jalkanen - Faron Pharmaceuticals Oy - CEO & Founder
We are very happy really to describe the year 2022, which is so transformative for us and excited about the prospects, what we have for this year, and we plan to cover those with you. And obviously, as you are well aware, we are a public company and we will be making a lot of forward-looking statements. And this is the disclaimer, really those. And we move on and I'll let Toni to start. Toni, please.
Toni Hänninen - Faron Pharmaceuticals Oy - CFO
Thank you, Markku. So Faron at glance, so just to recap who we are, Faron, a biotech company from Turku. We are dual listed in Helsinki and London. Our market cap roughly EUR245
Full Year 2022 Faron Pharmaceuticals Oy Earnings Call Transcript
Mar 02, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers